ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

Sandra Horning elected ASCO president-elect.

February 27, 2004

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002